Page results
-
Medtronic have informed us that there is a potential issue relating to the battery cap on some Medtronic insulin pumps (including 640, 670 and 780 series pumps).
-
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
This week, clinical leaders across north central London have written to our local newspapers, outlining the rationale for temporary changes to children and young people's services across the region. The letter reflects on some of the lessons learnt from the first wave of the COVID-19 pandemic and the need to plan ahead for a likely second surge and a busy winter with all of the challenges that will bring. You can read the letter in full here:
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
This page has been written to answer some common questions about Tofersen treatment for patients, as well as their caregivers and families.
-
This page has been written for parents and carers whose child is having a single fraction (one treatment) total body irradiation (TBI) for a benign (non-cancerous) blood disorder such as sickle cell anaemia, aplastic anaemia, thalassaemia, or some other condition.
-
This page has been written for children and young people and explains what deinfibulation is.
-
UCLH is committed to following a set of principles on how the trust will use routinely collected patient data for research. The principles will enable vital health research to take place, while at the same time protecting and using clinical data as patients would expect.
-
This page answers common questions about Acute Pancreatitis and how it is managed in North Central London (NCL).
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
File results
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0344 - Number of neonatal and stillbirth deaths since January 2013
-
FOI/2023/0345 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2023/0352 - Data security training, data breach reporting, security budgets
-
FOI/2023/0353 - Junior doctors remuneration for days on strike/will be on strike
-
FOI/2023/0356 - Current wait time for referral to treatment with a consultant for osteoporosis
-
FOI/2023/0358 - Diagnosis of POTS syndrome (postural orthostatic tachycardia syndrome (PoTS))
-
FOI/2023/0359 - Medicines management/ prescribing/ formulary committees at Trust
-
FOI/2023/0367 - IT estate